GSPCROP · GSP Crop Science Ltd · Chemical Manufacturing
GSPCROP · GSP Crop Science Ltd · Chemical Manufacturing
As of 05 Nov close
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old
Revenue (latest Q)
₹386 Cr
Revenue YoY
PAT YoY
+12.3%
Operating margin
Revenue, last 7 quarters
P/E (TTM)
P/B
3
P/S (TTM)
1.7
Sector P/E
20.6
Dividend yield
+0.2%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| GSPCROP (this stock) | 54.4 | 3 | +2.7% | +4.7% | 0.34 | +0.2% |
| Asian Paints | 53 | 11.1 | +12.8% | +22.3% | 0.18 | +1.1% |
| Solar Industries India | 102.6 | 27.4 | +17.6% | +31.4% | 13.68 | +0.1% |
| Pidilite Industries | 61.3 | 19.4 | +17.2% | +24.4% | 0.04 | +0.7% |
Promoter
stable
FII
falling 2q
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
| date | canonicalSymbol | buy quantity | buyer count | deal strength | deal types present |
|---|---|---|---|---|---|
| 2026-07-06 | GSPCROP | 405000 | 1 | STRONG | BULK |
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: During the Q1 FY27 earnings conference call held on August 12, 2026, GSP Crop Science Limited reported stable financial performance with a revenue of INR 386 crores, up from INR 377 crores in the same quarter last year. Management highlighted a strong domestic business, particularly in patented products, which contributed to volume growth. The company operates across three channels: domestic B2B, domestic B2C, and exports, with a current mix of approximately 45% each for B2B and B2C, and 10% for exports. Management noted improvements in gross margins due to a shift towards specialty products, despite facing temporary raw material constraints. Profit after tax increased by 16% to INR 26.4 crores. The company aims to double its share of patented products in the B2C segment over the next three years and is focusing on expanding its international presence, particularly in Latin America. The call concluded with management expressing optimism about future growth prospects.
Management emphasized stable performance and growth opportunities in patented products.
Sourced from an exchange-filed transcript, dated 17 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation from GSP Crop Science Limited, dated August 12, 2026, provided an overview of the company's financial performance for the quarter ended June 30, 2026. The presentation reported a revenue from operations of ₹3,860 million, reflecting a 2.4% year-over-year increase. Gross profit grew by 9.6% to ₹1,424 million, with a gross profit margin of 36.9%. The document highlighted the company's strong domestic business and a 20% increase in international business revenue, driven by sales in Brazil, the USA, and Africa. GSP Crop Science emphasized its robust product portfolio, including 303 registrations and a focus on innovation through R&D, with 112 patents granted. The management outlined strategic goals for future growth, including expanding into new markets and enhancing manufacturing capabilities. The presentation also detailed the utilization of IPO proceeds for debt repayment and general corporate purposes.
The presentation highlighted growth in revenue and profit, along with strategic plans for expansion.
Sourced from an exchange-filed presentation, dated 12 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: During the earnings conference call held on April 17, 2026, GSP Crop Science Limited management discussed the company's performance for the nine months ended December 31, 2025. Chairman Bhavesh Shah highlighted the company's strengths in manufacturing, R&D, and patenting, noting that GSP has launched 10 products in India that were previously imported. The company reported a revenue of INR 1,150 crores and an EBITDA of INR 153 crores, marking a 32% increase from the previous year. CFO Shail Shah elaborated on the company's three business verticals: domestic B2B, domestic B2C, and exports, with domestic operations contributing 80% of revenues. The management also addressed challenges such as rising raw material costs and supply chain issues due to geopolitical factors, stating that they have successfully passed on price increases to customers. The company aims to continue its growth trajectory through innovative product launches and strategic partnerships.
The management provided a balanced overview of the company's performance and challenges without overly positive or negative language.
Sourced from an exchange-filed transcript, dated 20 Apr 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for GSP Crop Science Limited, dated April 17, 2026, provided an overview of the company's business performance for the third quarter and nine months ended December 31, 2025. Management reported a 14% increase in revenue for 9MFY26, reaching ₹11,146 million, primarily driven by growth in the domestic B2C segment. EBITDA rose by 32% to ₹1,538 million, with an EBITDA margin improvement to 13.80%. The presentation highlighted the company's diverse product portfolio, strong R&D capabilities, and expansion into new markets, including Kerala and international regions such as Brazil and Africa. GSP Crop Science also noted a significant increase in patent registrations and a focus on innovative product development. The company operates five manufacturing facilities in India and emphasizes sustainability in its operations.
Management highlighted strong revenue and EBITDA growth along with strategic expansions.
Sourced from an exchange-filed presentation, dated 17 Apr 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedGSP Crop Science Limited's FY2025-26 annual report outlines the company's strategic priorities, including expanding manufacturing capacity, enhancing R&D capabilities, and strengthening its domestic and international distribution networks. The report highlights the company's focus on sustainability, corporate governance, and responsible growth, emphasizing its commitment to ESG principles and community engagement. It also acknowledges macroeconomic challenges, including global trade tensions and raw material cost volatility, while expressing cautious optimism about future prospects.
- Expansion of manufacturing capacity and backward integration to secure raw material supply
- Investment in in-house R&D for proprietary molecules and formulation optimization
- Extensive domestic distribution network with over 5500 active customers and dealers
- International diversification with exports to 40 countries and a subsidiary in Brazil
- Commitment to sustainability and ESG principles with recognized environmental and energy management certifications
Key takeaway: GSP Crop Science Limited is focusing on strategic expansion, R&D investment, and sustainability while managing risks related to supply chain dependencies and macroeconomic uncertainties.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Default / Covenant Breach (1 item)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Default / Covenant Breach
1 occurrenceRecent (last 12 months)
The excerpt mentions looking into reasons for substantial defaults in payments to depositors, debenture holders, and shareholders due to non-payment of declared dividends.
Routine disclosures
Contingent Liability
1 occurrenceRecent (last 12 months)
The company has disclosed contingent liabilities related to pending legal matters with future cash outflows determinable only upon receipt of judgments or decisions from various forums or authorities. The date of the hearing before the High Court is set for 3rd August, 2026.
Related-Party Transaction
1 occurrenceRecent (last 12 months)
The company has trade receivables from related parties, as disclosed in note 38, indicating transactions with entities where directors are partners, directors, or members.